Mexiletine?

What is Mexiletine Used For?

Mexiletine is an antiarrhythmic medication primarily used to treat abnormal heart rhythms, particularly ventricular arrhythmias [1]. It belongs to the class Ib antiarrhythmic drugs, which work by stabilizing the heart rhythm and preventing excessive electrical activity in the heart.

How Does Mexiletine Compare to Other Antiarrhythmic Drugs?

Mexiletine is often compared to other class Ib antiarrhythmic drugs, such as lidocaine and encainide. However, unlike some of these drugs, mexiletine is also approved for oral administration, making it a convenient treatment option [2]. Studies have shown that mexiletine is effective in treating ventricular arrhythmias, including ventricular tachycardia and fibrillation.

Why Are Companies Developing Mexiletine Formulations?

Several pharmaceutical companies are developing novel mexiletine formulations to improve its pharmacokinetics and stability. For example, a sustained-release formulation of mexiletine is being investigated for its potential to provide a more consistent and predictable dose of the medication [3]. Such developments aim to enhance the efficacy and tolerability of mexiletine in treating patients with abnormal heart rhythms.

When Does Exclusivity Expire?

The patent for mexiletine is expected to expire in [insert year], which may lead to the availability of generic versions of the medication. However, generic companies will need to meet specific regulatory requirements and demonstrate bioequivalence to the branded product to gain approval [4].

What are the Side Effects of Mexiletine?

Common side effects of mexiletine include tremors, muscle spasms, and nausea. In rare cases, the medication can cause more severe side effects, such as cardiac arrest, seizures, and respiratory depression [2]. Patients taking mexiletine should report any unusual symptoms to their healthcare provider promptly.

Who Makes Mexiletine?

Several pharmaceutical companies manufacture mexiletine, including Mylan, Pfizer, and West-Ward Pharmaceuticals. These companies offer varying strengths and formulations of the medication, including oral capsules and injectable solutions.

Sources:

[1] FDA. (2000). Mexiletine hydrochloride capsules for oral use.

[2] Drugs.com. (2023). Mexiletine.

[3] ClinicalTrials.gov. (2023). A study of a sustained-release mexiletine formulation.

[4] DrugPatentWatch.com. (2023). Mexiletine patent expiration date.